Painful Diabetic Neuropathy Treatment: A Guideline Topline
The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 21, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
HHS Will Award $103 Million to Reduce Burnout in Health Care Workforce
Funds will be used to develop institutional and community programs that target high stress health care work environments, already strained before the pandemic.
Two-thirds of Americans with Mental Illness Support Use of Psychedelics, Survey Finds
Americans with anxiety, depression, and PTSD would be willing to try ketamine, psilocybin, and MDMA if they worked better than traditional medications, a Harris Poll finds.
CDC: More Than 1 in 5 US Adults are Not Physically Active Enough
Updated state maps released today by the CDC show physical inactivity in the US differs by state, region, race, and ethnicity.
Blood Glucose Down, Insulin Sensitivity Up with 10 Minutes of Moderate-intensity Stair Stepping
Glucose and insulin levels decreased after just 3 minutes of the moderate-intensity exercise, a promising finding for those with type 2 diabetes, say authors of a new study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 19, 2022
CHD Prevalence in US Shows No Significant Change, According to BRFSS Analysis
Coronary heart disease prevalence in the US between 2011 and 2018 saw a statistically insignificant change, from 6.2% to 6.0%, respectively.
“Nocebo” Effect Accounted for Nearly Two-thirds of COVID-19 Vaccine Adverse Events in New Analysis
Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna Ryan, MD, wishes for universal understanding of obesity as a serious chronic disease, for a start. Her other wishes are equally ambitious.
8 New Drugs Approved for Primary Care: Q4 2021
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
CGM-derived Time in Range Found Similar to A1c for Predicting Microvascular Complications in T2D
Use of continuous glucose monitoring to assess time in target glucose range in T2D patients was evaluated in a systematic literature review covering ~14 000 participants.
At-home STD Tests in California Must be Covered by Insurance, says New Law
California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.
Less than 1 in 5 US Adults Meeting Heart Health Goals, According to AHA Scientific Statement
Available therapies combined with new approaches that address social determinants of health and other barriers to care can help, suggests new statement.
COVID-19 is a Cruel Reminder that Obesity IS a Disease, says Thought Leader Donna Ryan, MD
VIDEO Interview: The COVID-19 pandemic has closed what discussion remained about the status of obesity as a disease, according to obesity expert Donna Ryan, MD.
Obesity Expert Highlights 2021 Research Success, Looks to 2022 and Beyond
WATCH: The FDA approval of semaglutide 2.4 mg for adults with obesity was "by far the big event in 2021," said Donna Ryan, MD. More from our look back/look ahead interview, here.
Overweight, Obesity May Lead to More UK Hospitalizations than Previously Estimated
Using Mendelian randomization, a new study found in particular that waist-hip ratio may be a more important predictor of hospitalization than BMI.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
Seen in the ED: Positive Blood Culture
A man in his mid-60s presents after 1 month of intermittent fevers; recent blood cultures were positive for oral flora. Follow the ED course--can you make the diagnosis?